Clinical Trials- news for November 28th, 2024

The importance of Clinical Trials for finding way in preventing, detecting, or treating diseases, but limited participation creates challenges with meeting clinical trial goals.  After decades, recruitment still is a major challenge.

Alan Moss–MD< Chief Scientific Officer with the Crohn’s and Colitis Foundation, and people living with IBS–Inflammation Bowel Disease, said, “ Taking part in a clinical trial gives patients an opportunity to access new therapies and can help shape future treatment, including how diseases are diagnosed, treated, and even prevented.”

Finding a treatment which relieves patients symptoms and help indue and maintain remission is important.  These treatments would not be available without clinical trials.  All U.S. Food and Drug Administration–FDA– approve medications are the result of clinical trials and patients who participated in them.

There are many reason to participate in a clinical trial:  the safety– Investigational treatments must be studied extensively before the FDA will approve them.  Eligibility- participates in a clinical trial depends on the specific limits of the study. Treatment–when you participate in a clinical trial, you may have access to the study drug as a form of treatment. Cost–the majority of clinical trials are federally or privately funded.  Leaving the study– at any point you wish to drop out, you can.